Ceramide homeostasis in hepatic lipid droplets

Area of Science:

• Cell Biology
• Metabolic Biochemistry
• Hepatology

Background:

• Lipid droplets (LDs) are dynamic organelles involved in cellular energy homeostasis and stress response.
• Traditionally viewed as inert fat storage sites, LDs are now recognized as critical regulators of cellular metabolism and lipotoxicity.
• Ceramide, a bioactive sphingolipid, accumulates during conditions of fat oversupply and is implicated in metabolic diseases.

Purpose of the Study:

• To summarize current evidence on the role of ceramide in hepatic lipid droplet (LD) biogenesis.
• To delineate potential functions of ceramide in regulating LD formation and metabolism within liver cells.
• To highlight challenges and future directions in understanding ceramide's impact on hepatic LDs.

Main Methods:

• Literature review and synthesis of existing research on lipid droplets, ceramide, and liver metabolism.
• Focus on studies investigating ceramide's presence and enzymatic machinery within LDs.
• Analysis of data related to non-alcoholic fatty liver disease (NAFLD) as a model of hepatic metabolic stress.

Main Results:

• Sphingolipids and related enzymes are increasingly found associated with LDs, influencing their biogenesis and function.
• Ceramide accumulation in hepatocytes during fat oversupply suggests a role in modulating LD dynamics.
• Evidence points to ceramide's involvement in cellular responses to metabolic stress and lipotoxicity.

Conclusions:

• Ceramide plays a significant, yet not fully elucidated, role in the biogenesis and function of hepatic lipid droplets.
• Understanding ceramide's functions in LDs is crucial for deciphering the pathogenesis of non-alcoholic fatty liver disease.
• Further research is needed to overcome challenges in this novel field and fully characterize ceramide-LD interactions.